1. Home
  2. ALLO vs CIX Comparison

ALLO vs CIX Comparison

Compare ALLO & CIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.68

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo CompX International Inc.

CIX

CompX International Inc.

N/A

Current Price

$24.20

Market Cap

284.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLO
CIX
Founded
2017
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
284.2M
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
ALLO
CIX
Price
$2.68
$24.20
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$8.27
N/A
AVG Volume (30 Days)
5.5M
2.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
9.36%
EPS Growth
36.84
N/A
EPS
N/A
1.20
Revenue
$22,000.00
$145,941,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.18
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$17.89
52 Week High
$2.80
$32.30

Technical Indicators

Market Signals
Indicator
ALLO
CIX
Relative Strength Index (RSI) 70.55 55.03
Support Level $1.01 $22.71
Resistance Level N/A $24.87
Average True Range (ATR) 0.20 0.40
MACD 0.08 -0.02
Stochastic Oscillator 88.27 52.94

Price Performance

Historical Comparison
ALLO
CIX

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

Share on Social Networks: